// App-Quantinova.ai

578 : The Architecture Of Fibrin Clots Formed From Plasma With Low Platelet Levels Are Less Altered In The Presence Of Factor-Specific Anticoagulants Compared With Unfractionated Heparin

Researchers

Presenter

  • Jorell Gantioqui

Principal Investigators

  • Ivan Stevic

  • Paul Y. Kim

  • Keith K. Lau

  • Anthony K.C. Chan

  • Howard H.W. Chan

Medical Centers

  • Pediatrics, The Hong Kong University, Hong Kong, China

  • Thrombosis & Atherosclerosis Research Institute, Hamilton, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Medical Sciences Graduate Program, McMaster University, Hamilton, ON, Canada

  • Clinical Chemistry, University of Manitoba and Diagnostic Services of Manitoba, Winnipeg, MB, Canada

  • McMaster University, Hamilton, ON, Canada

Locations

  • Canada

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Fondaparinux sodium

  • rivaroxaban

  • dalteparin Subcutaneous

  • Pradax

  • Heparin

  • Trypsin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved